BridgeMD
New treatment option for Advanced Cancer
Official title Contrast-enhanced CBCT With C-arm HyperSight Technology
ClinicalTrials.gov ID: NCT07648160
What this study is testing
- What it's testing
- This is a single-arm prospective, feasibility study evaluating the intravenous contrast-enhanced cone beam computed tomography (IV CBCT) for image guidance during radiotherapy. Patients treated with SFRT will receive IV-contrast enhanced CT and fMRI before treatment for simulation purposes.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Primary biopsy-proven cancer
- Planning to undergo spatially fractionated radiation therapy
- Able to provide informed consent
- Willingness to participate in follow-up
- ECOG less than or equal to 3
You likely can't join if
- Unable to understand/provide consent
- History of allergic reaction to iodinated IV contrast dye (allergy to MR contrast is not an exclusion criteria)
- Known renal disease
- Single kidney
- Kidney transplant
- Dialysis
See the full eligibility criteria
- Primary biopsy-proven cancer
- Planning to undergo spatially fractionated radiation therapy
- Able to provide informed consent
- Willingness to participate in follow-up
- ECOG less than or equal to 3
- Normal creatinine (below 109mmol/L), normal eGF
- Unable to understand/provide consent
- History of allergic reaction to iodinated IV contrast dye (allergy to MR contrast is not an exclusion criteria)
- Known renal disease
- Single kidney
- Kidney transplant
- Dialysis
- Contraindication to MRI
The study team makes the final eligibility decision.
Where it's taking place
- Toronto, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Toronto, Ontario, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.